Home   /   Node   /   325658

Revisions for Singapore firm Esco Lifesciences closes US$200 mil Series A round with Novo, GIC among backers

RevisionOperations
Sat, 06/26/2021 - 19:38 by Anonymous (not verified)
This is the published revision.
×